HealthcareServices

Cloud-Based Rare Disease Family Registry Industry Poised for Rapid Growth, Forecast to Touch $3.14 Billion by 2030 at 17.5% CAGR

February 23, 2026February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the cloud-based rare disease family registry market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Cloud-Based Rare Disease Family Registry Market covering 2026–2035?

The cloud-based rare disease family registry market size has experienced rapid expansion in recent years. It is projected to increase from $1.4 billion in 2025 to $1.65 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 17.7%. The growth observed in the historic period can be attributed to the growth of rare disease research initiatives, increasing patient advocacy involvement, expansion of clinical trial networks, rising adoption of electronic data capture tools, and the need for centralized patient data systems.

The market size for cloud-based rare disease family registries is set for rapid expansion over the next few years. It is forecast to grow to $3.15 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 17.5%. This growth during the forecast period is attributable to increasing investments in orphan drug development, a rising demand for the generation of real-world evidence, the expansion of precision medicine research, the growing adoption of AI-driven data analytics, and an increasing emphasis on patient-centric research models. Major trends anticipated in this period include the increasing adoption of cloud-based patient registries, the rising use of digital platforms for rare disease research, the growing integration of genomic and clinical data, the expansion of global clinical trial recruitment tools, and an enhanced focus on secure data sharing.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28178&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Cloud-Based Rare Disease Family Registry Market?

A rising emphasis on precision medicine is projected to stimulate the expansion of the cloud-based rare disease family registry market moving forward. This medical approach tailors treatment and prevention strategies to an individual’s genetic, environmental, and lifestyle factors. The growth of precision medicine is driven by advances in genomic sequencing, which enable doctors to understand patients’ genetic makeup with greater accuracy. Cloud-based rare disease family registries bolster precision medicine by gathering and centralizing comprehensive patient data, including genetic, clinical, and treatment information. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the Food and Drug Administration (FDA), a US-based federal agency, approved 16 new personalized therapies for patients with rare diseases, marking a notable rise from the six approvals in 2022; of these newly authorized treatments, seven target cancer, while three focus on other diseases and conditions. Consequently, an increasing focus on precision medicine is fueling the growth of the cloud-based rare disease family registry market.

What Leading Segments Are Studied In The Cloud-Based Rare Disease Family Registry Market?

The cloud-based rare disease family registry market covered in this report is segmented –

1) By Component: Software, Services

2) By Deployment Mode: Public Cloud, Private Cloud, Hybrid Cloud

3) By Application: Patient Data Management, Research, Clinical Trials, Genetic Data Collection, Other Applications

4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Patient Advocacy Groups, Other End-Users

Subsegments:

1) By Software: Electronic Data Capture, Data Management Platform, Analytics And Reporting Tools, Patient Engagement Tools, Clinical Trial Management System

2) By Services: Implementation And Integration, Training And Support, Data Hosting And Security, Consulting Services, Maintenance And Upgrades

Which Trends Are Shaping Activity Within The Cloud-Based Rare Disease Family Registry Market?

Major companies in the cloud-based rare disease family registry market are driving technological innovations, such as bilingual federated registries, to provide secure, multi-location data platforms for patients, families, and researchers that enhance participation and support real-time data collection and analysis. A bilingual federated registry is a cloud-based system designed to allow data to remain at local sites while supporting multiple languages and complying with regional consent and privacy regulations. For instance, in June 2025, the National Organization for Rare Disorders (NORD), a U.S.-based nonprofit, planned the launch of two Canadian patient registries for PKU and MPS. Developed in collaboration with Canadian patient advocacy groups, researchers, and clinicians, these registries are the first in the IAMRARE Program to be hosted outside the U.S. They are designed to comply with provincial consent requirements, enable cooperative real-time data collection and analysis, and support efforts to accelerate research, improve understanding of rare metabolic disorders, and facilitate identification of participants for clinical trials.

Which Key Players Are Driving Competition In The Cloud-Based Rare Disease Family Registry Market?

Major companies operating in the cloud-based rare disease family registry market are Thermo Fisher Scientific Inc., IQVIA Holdings Inc., ICON plc, Syneos Health Inc., Parexel International Corp., Medidata Solutions Inc., FIGMD Inc., OM1 Inc., Mission Health Labs Inc., TREAT-NMD Global Registries Platform, Seqster PDM Inc., ArborMetrix Inc., OpenClinica LLC, Pulse Infoframe Inc., Oracle Healthcare Pvt. Ltd., QuesGen Systems Inc., FTD Disorders Registry, Castor LLC, Data Registry Services LLC, Fibrolamellar Registry, Rare Central

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cloud-based-rare-disease-family-registry-global-market-report

How Does The Cloud-Based Rare Disease Family Registry Market Perform Across Major Global Regions?

North America was the largest region in the cloud-based rare disease family registry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cloud-based rare disease family registry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cloud-Based Rare Disease Family Registry Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28178&type=smp

Browse Through More Reports Similar to the Global Cloud-Based Rare Disease Family Registry Market 2026, By The Business Research Company

Rare Diseases Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report

Patient Registry Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/patient-registry-software-global-market-report

Disease Management Apps Market Report 2026

https://www.thebusinessresearchcompany.com/report/disease-management-apps-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795